Vir Biotechnology, Inc. financial data

Symbol
VIR on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
1800 Owens Street, Suite 900, San Francisco, California
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 3, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 987 % +83.7%
Debt-to-equity 32.3 % -21%
Return On Equity -32.6 % -362%
Return On Assets -27 % -406%
Operating Margin -780 % -974%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 136 M shares +1.55%
Common Stock, Shares, Outstanding 136 M shares +1.43%
Entity Public Float 1.8 B USD -10%
Common Stock, Value, Issued 14 K USD +7.69%
Weighted Average Number of Shares Outstanding, Basic 135 M shares +1.29%
Weighted Average Number of Shares Outstanding, Diluted 135 M shares +1.29%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 79.6 M USD -82.2%
Cost of Revenue 917 K USD -98.4%
Research and Development Expense 532 M USD -1.83%
Costs and Expenses 701 M USD -9.06%
Operating Income (Loss) -621 M USD -91.6%
Nonoperating Income (Expense) 71 M USD +433%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -550 M USD -77%
Income Tax Expense (Benefit) -10.6 M USD
Net Income (Loss) Attributable to Parent -539 M USD -275%
Earnings Per Share, Basic -4.01 USD/shares -265%
Earnings Per Share, Diluted -4.01 USD/shares -271%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 161 M USD -80.5%
Marketable Securities, Current 985 M USD -30%
Cash, Cash Equivalents, and Short-term Investments 1.51 B USD -34.3%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Other Assets, Current 4.1 M USD -77.1%
Assets, Current 1.21 B USD -48.6%
Property, Plant and Equipment, Net 92.5 M USD -10.9%
Operating Lease, Right-of-Use Asset 70.3 M USD -13.7%
Intangible Assets, Net (Excluding Goodwill) 22.5 M USD -31.1%
Goodwill 16.9 M USD 0%
Assets 1.79 B USD -32.7%
Accounts Payable, Current 7.11 M USD -41.4%
Liabilities, Current 94.1 M USD -80.6%
Deferred Income Tax Liabilities, Net 3.25 M USD -82.4%
Operating Lease, Liability, Noncurrent 109 M USD -10.1%
Other Liabilities, Noncurrent 14.2 M USD +72.9%
Liabilities 247 M USD -64.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.4 M USD +25.5%
Retained Earnings (Accumulated Deficit) -303 M USD -228%
Stockholders' Equity Attributable to Parent 1.97 B USD -1.51%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 1.55 B USD -21.5%
Liabilities and Equity 1.79 B USD -32.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -109 M USD +13%
Net Cash Provided by (Used in) Financing Activities 152 K USD -93.5%
Net Cash Provided by (Used in) Investing Activities 28.4 M USD -71%
Common Stock, Shares Authorized 300 M shares 0%
Common Stock, Shares, Issued 136 M shares +1.43%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -80.8 M USD -219%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 180 M USD -78.6%
Deferred Tax Assets, Valuation Allowance 357 M USD +74.4%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 250 M USD +158%
Operating Lease, Liability 125 M USD -2.68%
Depreciation 4.4 M USD -20%
Payments to Acquire Property, Plant, and Equipment 1.87 M USD -72.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -539 M USD -279%
Lessee, Operating Lease, Liability, to be Paid 156 M USD -10.6%
Property, Plant and Equipment, Gross 131 M USD +0.47%
Operating Lease, Liability, Current 11.9 M USD +63.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 16.5 M USD -11.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 18.8 M USD -3.35%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Deferred Income Tax Expense (Benefit) -1.06 M USD +93%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 31.9 M USD -17%
Lessee, Operating Lease, Liability, to be Paid, Year Three 16.9 M USD +3.88%
Deferred Tax Assets, Operating Loss Carryforwards 138 M USD +835%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) -406 K USD +97.3%
Current Income Tax Expense (Benefit) -12 M USD -105%
Preferred Stock, Shares Authorized 10 M shares 0%
Unrecognized Tax Benefits 13.9 M USD +23%
Lessee, Operating Lease, Liability, to be Paid, Year Four 17.1 M USD +2.19%
Operating Lease, Payments 19.6 M USD +54%
Additional Paid in Capital 1.85 B USD +6.63%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 685 K USD -71.8%
Current Federal Tax Expense (Benefit) -12.8 M USD -105%
Amortization of Intangible Assets 531 K USD -0.19%
Depreciation, Depletion and Amortization 17.8 M USD +70%
Share-based Payment Arrangement, Expense 110 M USD +7.17%
Deferred State and Local Income Tax Expense (Benefit) -598 K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%